Background Image
Table of Contents Table of Contents
Previous Page  7 / 74 Next Page
Information
Show Menu
Previous Page 7 / 74 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 5, September/October 2018

AFRICA

269

related cardiomyopathy.

7-9

Recently, in addition to the classical

risk factors, there is an increasing body of evidence linking lone

AF to several novel genetic, molecular and pathophysiological

mechanisms, thereby making it a ‘not-so-lone AF’.

10,11

The autonomic nervous system plays an integral role in the

onset and offset of AF. Triggers for AF include adrenergic-

mediated states such as the alcohol-associated ‘holiday heart’,

12,13

caffeine

14

and dehydration.

15

This can be contrasted with vagally-

mediated states such as sleep, postprandial and post-exercise

situations that tend to be triggers for AF in tall, lean and

physically fit middle-aged males involved in endurance sports.

16-19

On the other hand, the pathophysiology of AF noted in

overweight patients has been linked to the inflammatory state

associated with the metabolic syndrome.

20,21

There are several

subsets of lone AF, including familial AF

22-24

and AF associated

with conduction system disorders, such as sick sinus syndrome

(SSS) or the bradycardia–tachycardia syndrome.

25

In the near

future it is hoped that elucidating the aetiology of lone AF

will lead to a more tailored and therapeutic approach to the

management of AF.

To the best of our knowledge, there are no studies to describe

the clinical characteristics and outcomes of patients with lone

AF in Africa and other developing regions of the world. The

purpose of this study was to describe the clinical characteristics

and outcomes of patients with lone AF attending Groote Schuur

Hospital (GSH) in Cape Town.

Methods

This study was a retrospective, descriptive study of the clinical

characteristics and outcomes of patients with lone AF who

attended GSH from January 1992 to December 2006. All

medical records of patients with AF over this 15-year period

were reviewed to identify those with lone AF. The patients had

presented to GSH Emergency Department, had already been

attending the Cardiac Clinic or had been referred to the Cardiac

Clinic from day hospitals or private medical institutions. The

medical records were reviewed for findings of their clinical

examinations, electrocardiograms, echocardiograms, chest

X-rays, laboratory results and, if clinically indicated, the 24-hour

Holter, exercise stress test and coronary angiograms.

Our inclusion and exclusion criteria were comparable to the

Mayo Clinic series,

2,3

the exception being the subset of patients

who had AF and concomitant SSS, which we included in the

study. Patients with any of the following at the initial diagnosis

of AF were excluded from the study: hypertension treated with

medication, or systolic blood pressure

>

160 mmHg or diastolic

blood pressure

>

90mmHg on two or more consecutive occasions;

coronary artery disease according to clinical or laboratory data;

hyperthyroidism as per laboratory data; left bundle branch

block or pre-excitation on electrocardiogram; valvular heart

disease; chronic obstructive airway disease; idiopathic dilated

cardiomyopathy; and patients who developed atrial fibrillation in

the context of an acute medical or surgical condition.

We included patients with systolic blood pressures recorded

between 140 and 160 mmHg or diastolic pressures between 80

and 90 mmHg on fewer than two consecutive occasions, as long

as there was no evidence of left ventricular hypertrophy on the

electrocardiogram or echocardiogram; elderly patients over

60 years, to assess their clinical characteristics and outcomes;

patients with documented AF and concomitant flutter or SSS;

and those with documented echocardiograms. More inclusion

criteria than those used in previous studies were chosen, to

investigate a population without any evidence of organic heart

disease at the first presentation, which may reflect what is

commonly found in clinical practice.

Although the Mayo Clinic series

2,3

did not include patients

with AF/SSS, a subsequent study

25

did include these subjects.

Patients who had symptoms and signs of heart failure and/

or a dilated left ventricle on echocardiogram in the absence of

classical risk factors or metabolic causes and with a normal QRS

duration and morphology at the initial diagnosis of AF (normal

apart from the AF) were included only if they demonstrated a

subsequent improvement of their symptoms and signs of heart

failure and left ventricular function on repeat echocardiogram,

once their rate was controlled.

The following baseline characteristics were entered into a

data-entry form: age at diagnosis, follow-up time, gender and race

(white, black or mixed race). The height and weight of patients

were noted and a body mass index of

<

25 kg/m

2

was considered

normal and

>

25 kg/m

2

was considered to be overweight. The

type of AF (paroxysmal or persistent) and the number of

patients who progressed from paroxysmal to permanent AF,

and subsets of patients with atrial flutter and conduction system

disease were noted. Family history was reviewed. Presenting

symptoms, their duration and possible triggering factors were

noted. Mortality rate and complications, including tachycardia-

related cardiomyopathy and thromboembolism were recorded.

Therapy instituted to control or terminate the AF was

reviewed. The indications and therapy chosen for prevention of

thromboembolism were reviewed. The number of patients who

developed bleeding complications while on anticoagulants was

also reviewed.

Baseline descriptive statistics were expressed as means and

range for continuous variables. Counts with percentages were

used for categorical variables.

Results

Of the 289 patients with AF in the period under review, 42 were

identified as having lone AF (15% of all patients with AF).

The mean follow-up time of these patients was 5.8 years. Males

comprised 57% (

n

=

24), and 43% (

n

=

18) were females. The

mean age of the males at diagnosis was 46 years with no males

being older than 60 years. The mean age of the females was 62.4

years; 55% (

n

=

10) were less than 65 years of age at the time of

diagnosis and they had a mean age of 45 years. The remaining

45% (

n

=

8) were older than 65 years.

The racial composition was 50% (

n

=

21) white, 36% (

n

=

15)

mixed race, 7% (

n

=

3) black and 7% (

n

=

3) not having their race

specified. Forty three per cent (

n

=

18) of patients were of normal

weight, 36% (

n

=

15) were overweight and 21% (

n

=

9) were not

specified.

At the time of diagnosis, 50% (

n

=

21) of the patients had

paroxysmal AF, 29% (

n

=

12) had persistent AF and 12% (

n

=

5)

progressed from paroxysmal to permanent AF over the follow-

up period. Subsets of AF included those with concomitant atrial

flutter (17%) (

n

=

7) and those with SSS (21%) (

n

=

9). A family

history of AF or palpitations was poorly documented in the

medical records.